The most important upcoming catalyst in neuroscience is Eli Lilly's TRAILBLAZER-ALZ 3 study, which aims to prevent Alzheimer's in at-risk patients. A positive result is expected to show a much larger effect size than seen in treating existing disease, potentially creating a massive new market and shifting the entire neurodegenerative paradigm.

Sensory decline, like hearing loss or cataracts, is linked to a higher risk of dementia, likely due to reduced brain stimulation and social engagement. However, this risk appears to be reversible. Interventions like cataract surgery or hearing aids restore sensory input, effectively eliminating the added risk.

Longitudinal studies reveal cognitive decline isn't linear but occurs in significant, stepwise drops following major illnesses or hospitalizations. A key strategy for maintaining brain function is minimizing the chance of getting seriously sick, as these events can cause lasting cognitive setbacks.

Al Sandrock predicts Alzheimer's treatment will shift from managing symptoms to prevention. Like cholesterol, amyloid buildup will be monitored via routine blood tests, allowing for treatment to be administered early to prevent irreversible neuron loss before cognitive impairment begins.

The focus in Alzheimer's treatment is moving from merely slowing decline in late-stage patients to early prevention. By using anti-amyloid drugs to clear plaques before significant brain damage occurs, it may be possible to prevent the disease's onset entirely.

A Finnish public health initiative aimed at reducing heart attacks through lifestyle changes—better diet, exercise, and smoking cessation—had an unintended, powerful consequence. The same interventions led to a significant reduction in dementia rates, proving that cardiovascular and brain health are deeply linked.

Despite common belief, only about 3-5% of Alzheimer's cases are driven by inherited genetic mutations. The vast majority are linked to lifestyle factors like diet, exercise, and sleep, making it a largely preventable disease if proactive measures are taken early in life.

Contrary to the popular belief that dementia is a growing crisis, age-adjusted data from North America and Europe shows a steady and significant decrease in prevalence. This suggests that public health and lifestyle changes are having a massive, under-recognized impact on neurodegenerative disease.

Major age-related illnesses like cancer, heart disease, and dementia share a common root cause: the biological process of aging. Slowing the decline of aging would be a more effective strategy for preventing these diseases than tackling each one individually, leading to more healthy years of life.